GLP-1 agonists and lean body mass loss part 2 w/ Dr. Grant Tinsley

Drs. Karl and Spencer bring back Dr. Grant Tinsley, a body composition researcher, to go over the GLP-1 data (semaglutide and tirzepatide) in terms of lean body mass loss.

Learn:

- How much lean body mass is lost in these trials

- How body composition is measured

- How is muscle loss assessed

- Should you be worried if you're taking a GLP-1 agonist

Read Dr. Tinsley's blog

Become a Sequence patient (evaluation for GLP-1 agonist)